Affymax, Zensys, Fiber Tower, Labcyte, and more...
Boston Scientific's blockbuster medical device--and the novel way it was developed
Salesforce.com is making software-as-a-service a popular idea.
The company's proposed method for accounting for employee stock options would affect all of Silicon Valley.
Corporate labs do well to indulge their inner visionaries.
Katsushi Ikeuchi wants to change our relationship with computers.
Energy investors get great stock performances--plus cash!
Technology Review’s annual look at research trends in corporations is led this year by pharmaceutical and biotech companies.
Osiris Therapeutics, Miasole, PicoChip, and more
Apple sees greater risk in staying with IBM's chips than in aligning itself with Intel.